All Products

Featured Products

Newest Products

Research Areas

PKG Drug G1
new
featured

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555755

CAS#: 374703-78-3

Description: PKG drug G1 is an activator of protein kinase GIα (PKGIα).


Price and Availability

Size Price Shipping out time Quantity
100mg USD 750 2 Weeks
200mg USD 1250 2 Weeks
500mg USD 1950 2 Weeks
1g USD 2950 2 Weeks
2g USD 5250 2 Weeks
Inquire bulk and customized quantity
Pricing updated 2020-10-26. Prices are subject to change without notice.

PKG Drug G1 is in stock.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 555755
Name: PKG Drug G1
CAS#: 374703-78-3
Chemical Formula: C13H11N3OS
Exact Mass: 257.0623
Molecular Weight: 257.311
Elemental Analysis: C, 60.68; H, 4.31; N, 16.33; O, 6.22; S, 12.46


Synonym: PKG Drug G1

IUPAC/Chemical Name: 5-[(2-methyl-1H-indol-3-yl)methylene]-2-thioxo-4-imidazolidinone

InChi Key: SNLLEQAPNVMOOT-WDZFZDKYSA-N

InChi Code: InChI=1S/C13H11N3OS/c1-7-9(6-11-12(17)16-13(18)15-11)8-4-2-3-5-10(8)14-7/h2-6,14H,1H3,(H2,15,16,17,18)/b11-6-

SMILES Code: O=C(/C(N1)=C/C2=C(C)NC3=C2C=CC=C3)NC1=S


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1. Burgoyne, J.R., Prysyazhna, O., Richards, D.A., et al. Proof of principle for a novel class of antihypertensives that target the oxidative activation of PKG Iα (protein kinase G Iα). Hypertension 70(3), 577-586 (2017).